Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5369_Библиотеки_им_академика_М_И_Перельмана
.pdf
68
68
Ichim, M. C. & Booker, A. (2021). Chemical authentication of botanical ingredients: a
Quantitative and Qualitative Determination of Counterfeit Drugs
review of commercial herbal products. Frontiers in Pharmacology. 12 (April): 666850.
doi: org/ 10.3389/ fphar.2021.666850.
Janvier, S., De Sutter, E., Wynendaele, E., De Spiegeleer, B., Vanhee, C., & Deconinck,
E. (2017). Analysis of illegal peptide drugs via HILIC- DAD- MS. Talanta. 174
(November): 562– 571. doi: org/ 10.1016/ j.talanta.2017.06.032.
Johansson, M., Fransson, D., Rundlöf, T., Huynh, N., and Arvidsson, T. (2012). A
general analytical platform and strategy in search for illegal drugs. Journal of
Pharmaceutical and Biomedical Analysis. 100 (November): 215– 229. doi: org/
10.1016/ j.jpba.2012.07.026.
Judák, P., Esposito, S., Coppieters, G., Van Eenoo, P., & Deventer, K. (2021). Doping control
analysis of small peptides: a decade of progress. Journal of Chromatography B. 1173
(May): 122551. doi: org/ 10.1016/ j.jchromb.2021.122551.
Kaltner, F., Kukula, V., & Gottschalk, C. (2020). Screening of food supplements for toxic
pyrrolizidine alkaloids. Journal of Consumer Protection and Food Safety, 15 (3): 237–
243. doi: org/ 10.1007/ s00003- 020- 01296- 9.
Kharbach, M., Marmouzi, I., El Jemli, M., Bouklouze, A., & Vander Heyden, Y. (2020).
Recent advances in untargeted and targeted approaches applied in herbal- extracts and
essential- oils ngerprinting – a review. Journal of Pharmaceutical and Biomedical
Analysis. 177 (January): 112849. doi: org/ 10.1016/ j.jpba.2019.112849.
Khuluza, F., Kigera, S., Jähnke, R. W. O., & Heide, L. (2016). Use of thin- layer
chromatography to detect counterfeit sulfadoxine/ pyrimethamine tablets with the
wrong active ingredient in Malawi. Malaria Journal. 15 (April): 215. doi: org/
10.1186/ s12936- 016- 1259- 9.
Kim, S. H., Lee, J., Yoon, T., Choi, J., Choi, D., Kim, D., & Kwon, S. W. (2009). Simultaneous
determination of anti- diabetes/ anti- obesity drugs by LC/ PDA, and targeted
analysis of sibutramine analog in dietary supplements by LC/ MS/ MS. Biomedical
Chromatography: BMC. 23 (12): 1259– 1265. doi: org/ 10.1002/ bmc.1248.
Knoop, A., Thomas, A., Fichant, E., Delahaut, P., Schänzer, W., & Thevis, M. (2016).
Qualitative identication of growth hormone- releasing hormones in human plasma
by means of immunoafnity purication and LC- HRMS/ MS. Analytical and
Bioanalytical Chemistry. 408 (12): 3145– 53. doi: org/ 10.1007/ s00216- 016- 9377- 3.
Ko- Tsekpo, M. (2002). Institutionalization of African traditional medicine in health care
systems in Africa. African Journal of Health Sciences. 11 (1– 2): i– ii. doi: org/ 10.4314/
ajhs.v11i1.30772.
Kohler, M., Thomas, A., Geyer, H., Petrou, M., Schänzer, W., & Thevis, M. (2010).
Conscated black market products and nutritional supplements with non- approved
ingredients analyzed in the cologne doping control laboratory 2009. Drug Testing and
Analysis. 2 (11– 12): 533– 537. doi: org/ 10.1002/ dta.186.
Krug, O., Thomas, A., Malerød- Fjeld, H., Dehnes, Y., Laussmann, T., Feldmann, I.,
Sickmann, A., & Thevis, M. (2018). Analysis of new growth promoting black market
products. Growth Hormone & IGF Research. 41 (August): 1– 6. doi: org/ 10.1016/
j.ghir.2018.05.001.
Labadie, J. (2012). Forensic pharmacovigilance and substandard or counterfeit drugs. The
International Journal of Risk & Safety in Medicine. 24 (1): 37– 39. doi: org/ 10.3233/
JRS- 2012- 0551.
Lange, T., Walpurgis, K., Thomas, A., Geyer, H., & Thevis, M. (2019). Development
of two complementary LC– HRMS methods for analyzing Sotatercept in dried
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
69
HPLC for Analysis of Substandard and Falsified Medicinal Products
69
blood spots for doping controls. Bioanalysis. 11 (10): 923– 940. doi: org/ 10.4155/
bio- 2018- 0313.
Lauber, M. A., Koza, S. M., McCall, S. A., Alden, B. A., Iraneta, P. C., & Fountain, K. J.
2013. High- resolution peptide mapping separations with MS- friendly mobile phases
and charge- surface- modied C18. Analytical Chemistry 85 (14): 6936– 6942. doi: org/
10.1021/ ac401481z.
Lee, J. H., Han, J. H., Kim, S., Kim, N. S., Yoon, C. , Kim, J., & Baek, S. Y. (2021). Screening
sexual performance enhancing compounds and their analogues in counterfeit and
illicit erectile dysfunction drugs by high- performance liquid chromatography and
liquid chromatography- tandem mass spectrometry. Journal of Forensic and Legal
Medicine. 82 (August): 102222. doi: org/ 10.1016/ j.jm.2021.102222.
Lee, J. H., Park, H. N., Park, O. R., Kim, N. S., Park, S., & Kang, H. (2019). Screening
of illegal sexual enhancement supplements and counterfeit drugs sold in the online
and ofine markets between 2014 and 2017. Forensic Science International. 298
(May): 10– 19. doi: org/ 10.1016/ j.forsciint.2019.02.012.
Legrand, P., Dembele, O., Alamil, H., Lamoureux, C., Mignet, N., Houzé, P., & Gahoual, R.
(2022). Structural identication and absolute quantication of monoclonal antibodies
in suspected counterfeits using capillary electrophoresis and liquid chromatographytandem mass spectrometry. Analytical and Bioanalytical Chemistry, January. doi: org/
10.1007/ s00216- 022- 03913- y.
Liu, S. Y.,Woo, S. O. & Koh, H. L.. (2001). HPLC and GC- MS screening of Chinese proprietary
medicine for undeclared therapeutic substances. Journal of Pharmaceutical and
Biomedical Analysis. 24 (5– 6): 983– 92. doi: org/ 10.1016/ s0731- 7085(00)00571- 9.
Liu, Z., Ren, C., Jones, W., Chen, P., Seminara, S. B., Chan, Y., Smith, N. F., et al. (2013). LC–
MS/ MS quantication of a neuropeptide fragment kisspeptin- 10 (NSC 741805) and
characterization of its decomposition product and pharmacokinetics in rats. Journal of
Chromatography B. 926 (May): 1– 8. doi: org/ 10.1016/ j.jchromb.2013.02.027.
Marchand, A., Martin, L., Martin, J., Ericsson, M., & Audran, M. (2020). The case of the
EPO-poisoned syringe. Drug Testing and Analysis. 12 (5): 637– 640. doi: org/ 10.1002/
dta.2757.
Massart, Desiré L., ed. 1997. Handbook of Chemometrics and Qualimetrics. Data Handling
in Science and Technology, v. 20. Amsterdam; New York: Elsevier.
Mestria, S., Odoardi, S., Frison, G., & Strano Rossi, S. (2021). LC-HRMS characterization
of the skin pigmentation and sexual enhancers melanotan ii and bremelanotide sold
on the black market of performance and image enhancing drugs. Drug Testing and
Analysis 13 (4): 876– 882. doi: org/ 10.1002/ dta.2986.
Mikami, E., Goto, T., Ohno, T., Oka, H., & Kanamori, H. (2005). Simultaneous analysis of
seven benzodiazepines in dietary supplements as adulterants using high performance
liquid chromatography and its application to an identication system for diazepam.
Journal of Health Science. 51 (3): 278– 283. doi: org/ 10.1248/ jhs.51.278.
Miraldi, E., S. Ferri, and V. Mostaghimi. 2001. “Botanical Drugs and Preparations in the
Traditional Medicine of West Azerbaijan (Iran).” Journal of Ethnopharmacology 75
(2– 3): 77– 87. https:// doi.org/ 10.1016/ s0378- 8741(00)00381- 0.
Mongongu, C., Coudoré F., Domergue, V., Ericsson, M., Buisson, C., and Marchand,
A. (2021). Detection of long R 3 -IGF-I, Des(1-3)-IGF-I, and R 3 -IGF-I using
immunopurication and high resolution mass spectrometry for antidoping purposes.
Drug Testing and Analysis. 13 (7): 1256– 1269. doi: org/ 10.1002/ dta.3016.
70
70
Moriyasu, T., Shigeoka, S., Kishimoto, K., Ishikawa, F., Nakajima, J., Kamimura, H.,
Quantitative and Qualitative Determination of Counterfeit Drugs
& Yasuda, I. (2001). Identication system for sildenal in health foods. Yakugaku
Zasshi: Journal of the Pharmaceutical Society of Japan. 121 (10): 765– 769. doi: org/
10.1248/ yakushi.121.765.
Mosihuzzaman, M., & Iqbal Choudhary, M. (2008). Protocols on safety, efcacy,
standardization, and documentation of herbal medicine (IUPAC technical report). Pure
and Applied Chemistry. 80 (10): 2195– 2230. doi: org/ 10.1351/ pac200880102195.
Mutschlechner, B., Schwaiger, S., Tran, T. V. A., & Stuppner, H. (2018). Development of a
selective HPLC- DAD/ ELSD method for the qualitative and quantitative assessment of
commercially available Eurycoma longifolia products and plant extracts. Fitoterapia.
124 (January): 188– 192. doi: org/ 10.1016/ j.tote.2017.11.015.
Niederkoer, E. E., Phillips, D. A., Krastins, B., Kulasingam, V., Kiernan, U. A., Tubbs,
K. A., Peterman, S. M., et al. (2013). Targeted selected reaction monitoring mass
spectrometric immunoassay for insulin- like growth factor 1. Edited by John Matthew
Koomen. PLoS ONE 8 (11): e81125. doi: org/ 10.1371/ journal.pone.0081125.
Odoardi, S., Mestria S., Biosa G., Valentini V., Federici S., & Strano Rossi S. 2021. An
Overview on Performance and Image Enhancing Drugs (PIEDs) Conscated in
Italy in the Period 2017– 2019. Clinical Toxicology. 59 (1): 47– 52. doi: org/ 10.1080/
15563650.2020.1770277.
Pachaly, Peter, and Gesundheitshilfe Dritte Welt – German Pharma Health Fund, eds. 1992.
Simple Thin Layer Chromatographic Identication of Active Ingredients in Essential
Drugs. Gesundheitshilfe Dritte Welt. Aulendorf: ECV – Editio- Cantor- Verl.
Park, M., & Ahn, S. (2012). Quantitative analysis of sildenal and tadalal in various
fake drugs recently distributed in Korea: quantitative analysis of sildenal and
tadalal. Journal of Forensic Sciences. 57 (6): 1637– 1640. doi: org/ 10.1111/
j.1556- 4029.2012.02162.2.
Popławska, M., & Błażewicz, A. (2019). Identication of a novel growth hormone releasing
peptide (a glycine analogue of GHRP- 2) in a seized injection vial. Drug Testing and
Analysis. 11 (1): 162– 167. doi: org/ 10.1002/ dta.2467.
Poplawska, M., Blazewicz, A., Bukowinska, K., and Fijalek, Z. 2013. Application of
high- performance liquid chromatography with charged aerosol detection for
universal quantitation of undeclared phosphodiesterase- 5 inhibitors in herbal dietary
supplements. Journal of Pharmaceutical and Biomedical Analysis. 84 (October): 232–
243. doi: org/ 10.1016/ j.jpba.2013.06.018.
Poplawska, M., Blazewicz, A., Zolek, P., & Fijalek, Z. (2012). Determination of ibanserin
and tadalal in supplements for women sexual desire enhancement using highperformance liquid chromatography with tandem mass spectrometer, diode array
detector and charged aerosol detector. Journal of Pharmaceutical and Biomedical
Analysis. 94 (June): 45– 53. doi: org/ 10.1016/ j.jpba.2012.01.021.
Pratiwi, R., Fayza Dipadharma, R. H., Prayugo, I. J., & Layandro, O. A.. (2021). Recent
analytical method for detection of chemical adulterants in herbal medicine. Molecules
(Basel, Switzerland.) 26 (21): 6606. doi: org/ 10.3390/ molecules26216606.
Pribluda, V. S., Barojas, A., Añez, A., López C. G., Figueroa, R., Herrera, R., Nakao, G.,
et al. (2012). Implementation of basic quality control tests for malaria medicines
in Amazon Basin countries: results for the 2005– 2010 period. Malaria Journal. 11
(June): 202. doi: org/ 10.1186/ 1475- 2875- 11- 202.
Qureshi, Z. P., Norris, L., Sartor, O., McKoy, J. M., Armstrong, J., Raisch, D. W., Garg, V.,
Stafkey- Mailey, D., & Bennett, C. L. (2012). Caveat oncologist: clinical ndings and
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
71
HPLC for Analysis of Substandard and Falsified Medicinal Products
71
consequences of distributing counterfeit erythropoietin in the United States. Journal
of Oncology Practice. 8 (2): 84– 90. doi: org/ 10.1200/ JOP.2011.000325.
Rebiere, H., Grange, Y., Deconinck, E., Courselle, P., Acevska, J., Brezovska, K., Maurin,
J., et al. (2022). European ngerprint study on omeprazole drug substances using
a multi analytical approach and chemometrics as a tool for the discrimination of
manufacturing sources. Journal of Pharmaceutical and Biomedical Analysis. 208
(January): 114442. doi: org/ 10.1016/ j.jpba.2021.114442.
Reeuwijk, N. M., Venhuis, B. J., De Kaste, D., Hoogenboom, L. A. P., Rietjens, I. M. C. M.,
& Martena, M. J.. 2013. “Sildenal and analogous phosphodiesterase type 5 (PDE- 5)
inhibitors in herbal food supplements sampled on the Dutch market. Food Additives
& Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment.
30 (12): 2027– 2032. doi: org/ 10.1080/ 19440049.2013.848292.
Reichel, C. (2010). Practicing IEF- PAGE of EPO: the impact of detergents and sample
application methods on analytical performance in doping control. Drug Testing and
Analysis. 2 (11– 12): 603– 619. doi: org/ 10.1002/ dta.215.
Reichel, C., Farmer, L., Gmeiner, G., Walpurgis, K., & Thevis, M. (2018). Detection of
Sotatercept (ACE- 011) in human serum by SAR- PAGE and western single blotting.
Drug Testing and Analysis. 10 (6): 927– 937. doi: org/ 10.1002/ dta.2346.
Reichel, C., Gmeiner, G., & Thevis, M. (2019). Detection of black market Follistatin 342.
Drug Testing and Analysis. 11 (11– 12): 1675– 1697. doi: org/ 10.1002/ dta.2741.
Sacré, P., Deconinck E., Chiap P., Crommen J., Mansion F., Rozet E., Courselle P., &
De Beer J. O. 2011. Development and validation of a ultra- high- performance
liquid chromatography- UV method for the detection and quantication of erectile
dysfunction drugs and some of their analogues found in counterfeit medicines. Journal
of Chromatography. A. 1218 (37): 6439– 47. doi: org/ 10.1016/ j.chroma.2011.07.029.
Savaliya, A. A., Shah, R. P., Prasad, B., & Singh, S. (2010). Screening of Indian aphrodisiac
ayurvedic/ herbal healthcare products for adulteration with sildenal, tadalal and/ or
vardenal using LC/ PDA and extracted ion LC- MS/ TOF. Journal of Pharmaceutical
and Biomedical Analysis. 52 (3): 406– 409. doi: org/ 10.1016/ j.jpba.2009.05.021.
Semenistaya, E., Zvereva, I., Thomas, A., Thevis, M., Krotov, G., & Rodchenkov, G. 2015.
Determination of growth hormone releasing peptides metabolites in human urine
after nasal administration of GHRP- 1, GHRP- 2, GHRP- 6, Hexarelin, and Ipamorelin.
Drug Testing and Analysis. 7 (10): 919– 925. doi: org/ 10.1002/ dta.1787.
Sheshashena Reddy, T., Reddy, A. S., & Devi, P. S. (2006). Quantitative determination of
sildenal citrate in herbal medicinal formulations by high- performance thin- layer
chromatography. Journal of Planar Chromatography – Modern TLC. 19 (112): 427–
431. doi: org/ 10.1556/ JPC.19.2006.6.2.
Shewiyo, D. H., Kaale, E., Risha, P. G., Dejaegher, B., Smeyers- Verbeke, J., & Van der
Heyden, Y. (2009). Development and validation of a normal- phase high- performance
thin layer chromatographic method for the analysis of sulfamethoxazole and
trimethoprim in co- trimoxazole tablets. Journal of Chromatography. A. 1216
(42): 7102– 7107. doi: org/ 10.1016/ j.chroma.2009.08.076.
Shewiyo, D. H., Kaale, E., Ugullum, C., Sigonda, M. N., Risha, P. G. , Dejaegher, B.,
Smeyers- Verbeke, J., and Van der Heyden, Y. (2011). Development and validation of a
normal- phase HPTLC method for the simultaneous analysis of lamivudine, stavudine
and nevirapine in xed- dose combination tablets. Journal of Pharmaceutical and
Biomedical Analysis 54 (3): 445– 450. doi: org/ 10.1016/ j.jpba.2010.09.009.
72
72
Singh, S., Prasad, B., Savaliya, A., Shah, R., Gohil, V., & Kaur, A. (2009). Strategies for
Quantitative and Qualitative Determination of Counterfeit Drugs
characterizing sildenal, vardenal, tadalal and their analogues in herbal dietary
supplements, and detecting counterfeit products containing these drugs. TrAC Trends
in Analytical Chemistry. 28 (1): 13– 28. doi: org/ 10.1016/ j.trac.2008.09.002.
Skalicka- Woźniak, K., Georgiev, M. I., & Erdogan Orhan, I.. (2017). Adulteration of herbal
sexual enhancers and slimmers: the wish for better sexual well- being and perfect body
can be risky. Food and Chemical Toxicology. 108 (Pt B): 355– 362. doi: org/ 10.1016/
j.fct.2016.06.018.
Streit, R. (2017). Der Herceptin®- Fall: ein fälschungsfall von arzneimitteln größeren
ausmaßes. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz. 60
(11): 1203– 1207. doi: org/ 10.1007/ s00103- 017- 2622- 2.
Stypułkowska, K., Błażewicz, A., Maurin, J., Sarna, K., & Fijałek, Z. (2011). X- ray powder
diffractometry and liquid chromatography studies of sibutramine and its analogues
content in herbal dietary supplements. Journal of Pharmaceutical and Biomedical
Analysis 56 (5): 969– 975. doi: org/ 10.1016/ j.jpba.2011.08.028.
Tang, M. H. Y., Chen, S. P. L., Ng, S. W., Chan, A. Y. W., & Mak, T. W. L.. (2011). Case
series on a diversity of illicit weight- reducing agents: from the well known to the
unexpected. British Journal of Clinical Pharmacology. 71 (2): 250– 253. doi: org/
10.1111/ j.1365- 2125.2010.03822.2.
Temerdashev, A. Z., Azaryan, A. A., Labutin, A. V., Dikunets, M. A., Zvereva, I. O., Podol’skii,
I. I., Berodze, G. T., & Balabaev, I. A. (2017). Application of chromatography– mass
spectrometry methods to the control of sport nutrition and medicines marketed via
internet. Journal of Analytical Chemistry. 72 (11): 1184– 1192. doi: org/ 10.1134/
S1061934817110090.
Thevis, M., Bredehöft, M., Kohler, M., & Schänzer, W. 2009. Mass spectrometry- based
analysis of IGF- 1 and HGH. Doping in Sports, edited by Thieme D. & Hemmersbach P.,
195:201– 7. Handbook of Experimental Pharmacology. Berlin, Heidelberg: Springer.
doi: org/ 10.1007/ 978- 3- 540- 79088- 4_ 9.
Thevis, M., Kuuranne, T., Geyer, H., & Schänzer, W. (2012). Annual banned- substance
review: analytical approaches in human sports drug testing: annual bannedsubstance review. Drug Testing and Analysis. 6 (1– 2): 164– 82. doi: org/ 10.1002/
dta.1591.
Thevis, M., Thomas, A., & Schänzer, W. (2011). Doping control analysis of selected peptide
hormones using LC– MS(/ MS). Forensic Science International. 213 (1– 3): 35– 41.
doi: org/ 10.1016/ j.forsciint.2011.06.015.
Thomas, A., Geyer, H., Kamber, M., Schänzer, W., & Thevis, M. (2008). Mass spectrometric
determination of gonadotrophin-releasing hormone (GnRH) in human urine for
doping control purposes by means of LC– ESI-MS/ MS. Journal of Mass Spectrometry.
43 (7): 908– 915. doi: org/ 10.1002/ jms.1453.
Thomas, A., Höppner, S., Geyer, H., Schänzer, W., Petrou, M., Kwiatkowska, D., Pokrywka,
A., & Thevis, M. (2011). Determination of growth hormone releasing peptides
(GHRP) and their major metabolites in human urine for doping controls by means of
liquid chromatography mass spectrometry. Analytical and Bioanalytical Chemistry.
401 (2): 507– 516. doi: org/ 10.1007/ s00216- 011- 4702- 3.
Thomas, A., Kohler M., Mester J., Geyer H., Schänzer W., Petrou M., & Thevis M. (2010).
Identication of the growth- hormone- releasing peptide- 2 (GHRP- 2) in a nutritional
supplement. Drug Testing and Analysis, n/ a- n/ a. doi.org/ 10.1002/ dta.120.
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
73
HPLC for Analysis of Substandard and Falsified Medicinal Products
Thomas, A., Kohler, M., Schänzer, W., Delahaut, P., & Thevis, M. 2011. Determination of
73
IGF- 1 and IGF- 2, their degradation products and synthetic analogues in urine by LCMS/ MS. The Analyst. 136 (5): 1003– 12. doi: org/ 10.1039/ C0AN00632G.
Thomas, A., Krombholz, S., Wolf, C., & Thevis, M. (2021). Determination of ghrelin and
desacyl ghrelin in human plasma and urine by means of LC– MS/ MS for doping
controls. Drug Testing and Analysis. 13 (11– 12): 1862– 1870. doi: org/ 10.1002/
dta.3176.
Thomas, A., Schänzer, W., Delahaut, P., & Thevis, M. (2012). Immunoafnity purication
of peptide hormones prior to liquid chromatography– mass spectrometry in doping
controls. Methods. 56 (2): 230– 235. doi: org/ 10.1016/ j.ymeth.2011.08.009.
Thomas, A., Walpurgis, K., Delahaut, P., Fichant, E., Schänzer, W., & Thevis, M.( 2017).
Determination of longR 3 - IGF- I, R 3 - IGF- I, Des1- 3 IGF- I and their metabolites in
human plasma samples by means of LC- MS. Growth Hormone & IGF Research. 35
(August): 33– 39. doi: org/ 10.1016/ j.ghir.2017.06.002.
Tie, Y., Vanhee, C., Deconinck, E., & Adams, E. (2019). Development and validation of
chromatographic methods for screening and subsequent quantication of suspected
illegal antimicrobial drugs encountered on the Belgian market. Talanta 194
(March): 876– 887. doi: org/ 10.1016/ j.talanta.2018.10.078.
Tistaert, C., Dejaegher, B., & Van der Heyden Y. 2011. Chromatographic separation
techniques and data handling methods for herbal ngerprints: a review. Analytica
Chimica Acta. 690 (2): 148– 161. doi: org/ 10.1016/ j.aca.2011.02.023.
Tomić, S., Milcić, N., Sokolić, M., & Ilić Martinac, A. (2010). Identication of counterfeit
medicines for erectile dysfunction from an illegal supply chain. Arhiv Za Higijenu
Rada I Toksikologiju 61 (1): 69– 75. doi: org/ 10.2478/ 10004- 1254- 61- 2010- 1953.
Tshibangu, K. C., Worku, Z. B., De Jongh, M. A., Van Wyk, A. E., Mokwena, S. O., &
Peranovic, V. (2002). Assessment of effectiveness of traditional herbal medicine
in managing HIV/ AIDS patients in South Africa. East African Medical Journal 81
(10): 499– 502. doi: org/ 10.4314/ eamj.v81i10.9231.
United States Pharmacopoeia Convention. (2021). United Stated Pharmacopoeia (USP‑ NF
2021). Frederick, USA.
Van den Broek, I., Blokland, M., Nessen, M. A., & Sterk, S. (2015). Current trends in mass
spectrometry of peptides and proteins: application to veterinary and sports- doping
control: mass spectrometry for detection of peptide and protein growth promoters.
Mass Spectrometry Reviews. 34 (6): 571– 592. doi: org/ 10.1002/ mas.21419.
Vanhee, C., Francotte, A., Janvier, S., & Deconinck, E. (2020). The occurrence of putative
cognitive enhancing research peptides in seized pharmaceutical preparations: an
incentive for controlling agencies to prepare for future encounters of the kind. Drug
Testing and Analysis. 12 (3): 371– 381. doi: org/ 10.1002/ dta.2717.
Vanhee, C., Janvier S., Desmedt B., Moens G., Deconinck E., De Beer J. O., & Courselle
P. (2015). Analysis of illegal peptide biopharmaceuticals frequently encountered
by controlling agencies. Talanta. 142 (September): 1– 10. doi; org/ 10.1016/
j.talanta.2015.02.022.
Vanhee, C., Janvier, S., Moens, G., Deconinck, E., and Courselle, P. (2016). A simple
dilute and shoot methodology for the identication and quantication of illegal
insulin. Journal of Pharmaceutical Analysis. 6 (5): 326– 32. doi: org/ 10.1016/
j.jpha.2016.02.006.
Vanhee, C., Moens, G., Deconinck, E., & De Beer, J. O. (2012). Identication and
characterization of peptide drugs in unknown pharmaceutical preparations seized by
74
74
Quantitative and Qualitative Determination of Counterfeit Drugs
the Belgian authorities: case report on AOD9604: identication and characterisation of
peptide drugs. Drug Testing and Analysis. 6 (9): 964– 968. doi: org/ 10.1002/ dta.1687.
Vanhee, C., Moens, G., Van Hoeck, E., Deconinck, E., & De Beer, J. O. (2015).
Identication of the small research tetra peptide Epitalon, assumed to be a potential
treatment for cancer, old age and Retinitis Pigmentosa in two illegal pharmaceutical
preparations: identication and analysis of a new illegal biopharmaceutical. Drug
Testing and Analysis. 7 (3): 259– 262. doi: org/ 10.1002/ dta.1771.
Vanhee, C., Tuenter, E., Kamugisha, A., Canfyn, M., Moens, G., Courselle, P., Pieters,
L., et al. (2018). Identication and quantication methodology for the analysis of
suspected illegal dietary supplements: reference standard or no reference standard,
that is the question. Journal of Forensic Toxicology & Pharmacology. 07 (01). doi: org/
10.4172/ 2325- 9841.1000156.
Venhuis, B. J., Vredenbregt, M. V., Kaun, N., Maurin, J. K., Fijałek, Z., & De Kaste, D..
(2011). The identication of rimonabant polymorphs, sibutramine and analogues of
both in counterfeit acomplia bought on the internet. Journal of Pharmaceutical and
Biomedical Analysis. 54 (1): 21– 26. doi: org/ 10.1016/ j.jpba.2010.07.043.
Venhuis, B. J., Keizers, P. H. J., Klausmann R., & Hegger, I. (2016). Operation resistance: a
snapshot of falsied antibiotics and biopharmaceutical injectables in Europe. Drug
Testing and Analysis. 8 (3– 4): 398– 401. doi: org/ 10.1002/ dta.1888.
Venhuis, B.J. & De Kaste, D. (2012). Towards a decade of detecting new analogues of
sildenal, tadalal and vardenal in food supplements: a history, analytical aspects and
health risks. Journal of Pharmaceutical and Biomedical Analysis. 69 (October): 196–
208. doi: org/ 10.1016/ j.jpba.2012.02.012.
Voss, S. C., Orie, N. N., El-Saftawy, W., Saghbazarian, S., Al-Kaabi, A., Georgakopoulos, C.,
Athanasiadou, I., et al. (2021). Horseradish-peroxidase-conjugated anti-erythropoietin
antibodies for direct recombinant human erythropoietin detection: proof of concept.
Drug Testing and Analysis. 13 (3): 529– 538. doi: org/ 10.1002/ dta.2957.
Walpurgis, K., Thomas, A., Lange, T., Reichel, C., Geyer, H., & Thevis M. (2018). Combined
detection of the ActRII-Fc fusion proteins sotatercept (ActRIIA-Fc) and luspatercept
(modied ActRIIB-Fc) in serum by means of immunoafnity purication, tryptic
digestion, and LC-MS/ MS. Drug Testing and Analysis. 10 (11– 12): 1714– 1721.
doi: org/ 10.1002/ dta.2513.
Wang, J., Chen B., & Yao S. (2008). Analysis of six synthetic adulterants in herbal weight-
reducing dietary supplements by LC electrospray ionization- MS. Food Additives &
Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment. 25
(7): 822– 830. doi: org/ 10.1080/ 02652030801946553.
World Health Organisation (WHO). (2000). General guidelines for methodologies on
research and evaluation of traditional medicine. Geneva, Switzerland. apps.who.int/
iris/ bitstream/ handle/ 10665/ 66783/ WHO_ EDM_ TRM_ 2000.1.pdf;jsessionid= C4FB
9884E97C93CAB984CB430622F6F9?sequence= 1.
— — — . (2018). Substandard and Falsied Medical Products. World Health Organisation.
www.who.int/ news- room/ fact- she ets/ det ail/ subs tand ard- and- falsif ied- medi calprodu cts.
Wu, Y. (2006). The identication of microscopic, physical and chemistrical analysis on
Curculigo orchiode and its counterfeit. Journal of Chinese Medicinal Materials. 29
(6): 553– 552.
Yemoa, A., Habyalimana, V., Mbinze, J. K., Crickboom, V., Muhigirwa, B., Ngoya, A.,
Sacre, P., et al. (2017). Detection of poor quality artemisinin- based combination
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
75
HPLC for Analysis of Substandard and Falsified Medicinal Products
75
therapy (ACT) medicines marketed in Benin using simple and advanced
analytical techniques. Current Drug Safety. 12 (3): 178– 186. doi: org/ 10.2174/
1574886312666170616092457.
Yu, N. H., Ho, E. N. M., Wan, T. S. M., & Wong, A. S. Y.. (2010). Doping control analysis
of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene
glycol- epoetin beta in equine plasma by nano- liquid chromatography– tandem mass
spectrometry. Analytical and Bioanalytical Chemistry. 396 (7): 2513– 2521. doi: org/
10.1007/ s00216- 010- 3455- 8.
Yun, J., Shin K. J., Choi J., and Jo C. (2018). Isolation and structural characterization of a
novel sibutramine analogue, chlorosipentramine, in a slimming dietary supplement, by
using HPLC- PDA, LC- Q- TOF/ MS, FT- IR, and NMR. Forensic Science International.
286 (May): 199– 207. doi: org/ 10.1016/ j.forsciint.2018.03.021.
Zhu, X., Song, X., Chen. B., Zhang, F., Yao, S., Wan, Z., Yang, D., & Han, H. (2005).
Simultaneous determination of sildenal, vardenal and tadalal as forbidden
components in natural dietary supplements for male sexual potency by highperformance liquid chromatography- electrospray ionization mass spectrometry.
Journal of Chromatography. A. 1066 (1– 2): 89– 95. doi: org/ 10.1016/
j.chroma.2005.01.038.
Zou, P., Sze- Yin Oh, S., Hou, P., Low, M., & Koh, H. (2006). Simultaneous determination of
synthetic phosphodiesterase- 5 inhibitors found in a dietary supplement and pre- mixed
bulk powders for dietary supplements using high- performance liquid chromatography
with diode array detection and liquid chromatography- electrospray ionization tandem
mass spectrometry. Journal of Chromatography. A. 1104 (1– 2): 113– 122. doi: org/
10.1016/ j.chroma.2005.11.103.
Zvereva, I., Dudko G., & Dikunets M. (2018). Determination of GnRH and its synthetic
analogues’ abuse in doping control: small bioactive peptide UPLC- MS/ MS method
extension by addition of in vitro and in vivo metabolism data; evaluation of LH
and steroid prole parameter uctuations as suitable biomarkers. Drug Testing and
Analysis. 10 (4): 711– 722. doi: org/ 10.1002/ dta.2256.
76
Данная книга находится в списке для перевода на русский язык сайта https://meduniver.com/
77
Tackling a Global Crisis
3
A Review of the Efficacy
of LC- MS
Dong Hyeon Shin1 and Ronny Priefer
1
MCPHS University, 179 Longwood Ave, Boston, MA,
1,*
USA, 02115
CONTENTS
3.1 Introduction ................................................................................................. 77
3.2 Chromatography Coupled with Mass Spectrometry ................................... 78
3.3 Counterfeit Drugs for Pathogenic Diseases .................................................79
3.4 Counterfeit Drugs for Erectile Dysfunction ................................................ 82
3.5 Counterfeit Drugs for Steroids .................................................................... 85
3.6 Counterfeit Drugs for Obesity ..................................................................... 86
3.7 Concerning Counterfeit Drugs with Detrimental Effects ............................ 88
3.8 Conclusion ................................................................................................... 90
References .............................................................................................................91
3.1 INTRODUCTION
People in low and middle- income countries are prone to consume low- quality
medicines that can cause deleterious effects on the patient and the population as
a whole. According to the Centers for Disease Control and Prevention (CDC),
9%– 41% of medicines sold in these countries are counterfeit (1). Counterfeit
medicines are classied as either poor- quality, having sub- standard levels, or
containing no active ingredient/ s. As a result, there are increased risks of treatment
failure, prolonged illness, adverse reactions, and higher levels of morbidity and
mortality (2,3).
Based on the World Health Organization’s (WHO) estimates, over one million
deaths occur annually as a result of counterfeit drugs (4). In developed countries,
governments and organizations have put signicant efforts toward combatting their
distribution and production (5). However, due to lack of either infrastructure or
funds, this is a limitation in developing countries, thus leading to an increase in the
sales of these counterfeit medicines. It is estimated that more than 50% drugs sold
in parts of Africa and Asia are counterfeit (6). Counterfeit drugs are generally less
expensive, making them more affordable to the population living in low- income
countries. Moreover, those living in developing countries suffer from diseases that
DOI: 10.1201/9781003270461-3
77
Соседние файлы в папке Библиотека им академика М.И. Перельмана